Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …
AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
Covid‐19 and dengue: double punches for dengue‐endemic countries in Asia
Summary The coronavirus disease 2019 (Covid‐19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is an international public health crisis …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is an international public health crisis …
[HTML][HTML] Remdesivir and its antiviral activity against COVID-19: A systematic review
Background To summarize the antiviral activities of remdesivir against SARS-CoV-2, the
causative agent of COVID-19. Methods Available publications were systematically explored …
causative agent of COVID-19. Methods Available publications were systematically explored …
Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: their significant mutations in S‐glycoprotein, infectivity, re …
C Chakraborty, M Bhattacharya… - Reviews in Medical …, 2022 - Wiley Online Library
Newly arising variants of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
are now a threat to global public health and are creating COVID‐19 surges in different …
are now a threat to global public health and are creating COVID‐19 surges in different …
[HTML][HTML] Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms-a …
Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …
[HTML][HTML] Antivirals for COVID-19: a critical review
No specific drugs have been approved for coronavirus disease 2019 (COVID-19) to date as
the development of antivirals usually requires time. Therefore, assessment and use of …
the development of antivirals usually requires time. Therefore, assessment and use of …
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has been a global public health emergency since …
syndrome coronavirus 2 (SARS-CoV-2) has been a global public health emergency since …
An overview on the treatments and prevention against COVID-19
Y Panahi, AM Gorabi, S Talaei, F Beiraghdar… - Virology Journal, 2023 - Springer
Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …
Geriatric population during the COVID-19 pandemic: problems, considerations, exigencies, and beyond
The coronavirus disease 2019 (COVID-19) pandemic wreaked havoc worldwide, with more
than 20 million confirmed cases and nearly 0. 75 million deaths as of 10th August 2020 …
than 20 million confirmed cases and nearly 0. 75 million deaths as of 10th August 2020 …
Immunotherapeutic approaches to curtail COVID-19
COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …